Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016-12-20
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Related Questions
i.e. gross disease on scans that is too diffuse to be removed completely and/or decreasing but not normal markers
Do you pursue close surveillance, s...
New comment by Medical Oncologist at Indiana Univ Simon Cancer Center ( October 11, 2019)
There is never a problem with a declining marker, just with a rising one. if he is VERY fortunate, the residual mass will be necrosis and will slowly decrease in size with pas...